Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma

  title={Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma},
  author={Yu‐Kuei Chen and Chun-Wei Tung and Jui-Ying Lee and Yi-Chun Hung and Chien-Hung Lee and Shah Hwa Chou and Hung-Shun Lin and Ming-Tsang Wu and I-Chen Wu},
  journal={Scientific Reports},
This study aimed to identify noninvasive protein markers capable of detecting the presence and prognosis of esophageal squamous-cell carcinoma (ESCC). Analyzing microarray expression data collected from 17-pair ESCC specimens, we identified one protein, matrix metalloproteinase-1 (MMP1), as a possibly useful marker. Plasma MMP1 was then measured by enzyme-linked immunosorbent assay (ELISA) in 210 ESCC patients and 197 healthy controls. ESCC patients had higher mean levels of MMP1 than controls… 
Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses.
It is suggested that MMP1 may be pivotal to the transition from normal skin to premalignant lesions to SCC, thus representing a potential therapeutic target gene of diagnosis and prevention in SCC.
A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy
The study results suggest that the novel models integrating tumor length and tumor thickness may provide a simple and widely available method for evaluating the prognosis of non-operative ESCC patients.
Plasma proteomic biomarker signature of age predicts health and life span
Data support the use of proteomic biomarkers to monitor aging trajectories and to identify individuals at higher risk of disease to be targeted for in depth diagnostic procedures and early interventions.
CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.
This study is the first to identify the functions of CDKN3 in ESCC and provide evidence that CD KN3 regulates tumor progression by activating the AKT signaling pathway, and may serve as a potential effective therapeutic target for ESCC treatment.
Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy
LMR and NLR can be used to predict the survival of patients with advanced oesophageal cancer receiving concurrent chemoradiotherapy, thereby providing clinicians with suggestions for further treatment options.
Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis
To uncover the genes associated with the development of esophageal squamous cell carcinoma (ESCC), an ESCC microarray dataset was used to identify genes differentially expressed between ESCC and
The global expression profiling in esophageal squamous cell carcinoma.
ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers
Current knowledge on the role of ECM and its remodeling enzymes in affecting the growth and dissemination of UADT SCC is summarized to suggest that a thorough analysis of the ECM composition in the UADt SCC microenvironment may help disclosing the mechanism of resistance to the treatments and help defining possible targets for clinical intervention.
Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment
Expanded NK cells were highly cytotoxic against NKG2DLs-expressing ESCC cells, particularly the EMT phenotype, providing a strong rationale for clinical use of these NK cells in ESCC patients.


Matrix Metalloproteinases Expression Correlates with Survival in Patients with Esophageal Squamous Cell Carcinoma
MMP9 expression is a negative, independent prognostic factor in ESCC and correlates with tumor cell differentiation, vessel permeation, and lymph node metastasis, and correlated negatively with disease-free survival in relatively early stage ESCC patients.
MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma
  • Hong-hua Peng, Xi Zhang, P. Cao
  • Biology, Medicine
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • 2012
MMP-1 and PAR-1 were both overexpressed in ESCC and are novel predictors of poor patient prognosis after curative resection and might be a new therapeutic target for future therapies tailored against ESCC.
Overexpression of MMP-1 and VEGF-C is Associated with a Less Favorable Prognosis in Esophageal Squamous Cell Carcinoma
Protein expression was associated with progressive tumor stage and poor prognosis in patients with esophageal SCC, and median overall survival and disease-free survival were significantly shorter in Patients with a higher expression of MMP-1 and VEGF-C than in customers with lower expression levels.
Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer
MMP1 was identified to be associated with an increased risk for lung cancer, which was modified by smoking, and haplotype analysis supported these findings, especially for subgroups with high smoking intensity.
Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma
This study represents the first report of MMP1 as a biomarker with a higher sensitivity and specificity than AFP and could be used as novel biomarkers for the early detection of HCC and to improve the sensitivity of biomarkers compared with AFP.
The clinical significance of MMP-1 expression in oesophageal carcinoma
The results indicated that MMP-1 might play a crucial role in local invasion, but not in systemic dissemination, and might be a novel prognostic factor independent from those previously reported in oesophageal carcinoma.
MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status
expression of MMP-1 in proliferating BE and EAC cells suggest malignant proliferation following the clonal expansion model and suggest preinvasive factor in BE-associated EAC.
Matrix metalloproteinase‐1 is associated with poor prognosis in oesophageal cancer
The identification of individual MMPs in oesophageal cancer provides a rational basis for use in the treatment of oesophileal cancer of MMP inhibitors which are currently undergoing clinical trial.
Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets
Some of the challenges associated with MMP research are assessed as well as putative reasons for the conflicting data on the value of these enzymes as diagnostic and prognostic markers in cancer patients.